{"transactions":[{"id":4630920,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-10-05T21:27:13.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning August 19, 2026, 1/12th of the shares subject to the option vest in equal monthly installments over a one year period, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":20000,"derivative":{"exercise_price":1.64,"expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001823197-26-000002","document":"form4-10052026_091008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823197/000182319726000002/form4-10052026_091008.xml","form_type":"4"}},{"id":678566,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-08-21T22:47:28.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following the date of grant, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":10000,"derivative":{"exercise_price":0.6131,"expiration_date":"2036-08-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001823197-26-000001","document":"form4-08212026_100824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000182319726000001/form4-08212026_100824.xml","form_type":"4"}},{"id":1019028,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-10-14T16:22:17.000Z","date":"2025-10-13","kind":"grant","planned":false,"acquired":true,"shares":937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning October 1, 2025, 1/3rd of the shares subject to the option shall vest in equal monthly installments."}],"balance_after":937,"derivative":{"exercise_price":3.26,"expiration_date":"2035-10-12","underlying":"Common Stock","underlying_shares":937},"source":{"system":"sec-edgar","filing":"0001823197-25-000003","document":"form4-10142025_041014.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000182319725000003/form4-10142025_041014.xml","form_type":"4"}},{"id":1100859,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:23:49.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following June 24, 2025, provided that the shares will in any case be fully vested on the date of Company's 2026 annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":1.65,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018303","document":"form4-06262025_100646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018303/form4-06262025_100646.xml","form_type":"4"}},{"id":1100858,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:23:49.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/9th of the shares subject to the option vest in equal monthly installments over a one year period following April 1, 2025."}],"balance_after":15000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-25-018303","document":"form4-06262025_100646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018303/form4-06262025_100646.xml","form_type":"4"}},{"id":1100857,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:23:49.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":4166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":4166,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":4166},"source":{"system":"sec-edgar","filing":"0001415889-25-018303","document":"form4-06262025_100646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018303/form4-06262025_100646.xml","form_type":"4"}},{"id":1100856,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:23:49.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following March 26, 2025."}],"balance_after":10000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018303","document":"form4-06262025_100646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018303/form4-06262025_100646.xml","form_type":"4"}},{"id":1301340,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-01-17T00:51:03.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest in equal monthly installments over a three year period following the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":3.02,"expiration_date":"2035-01-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-25-001595","document":"form4-01172025_120159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925001595/form4-01172025_120159.xml","form_type":"4"}},{"id":2397724,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-02-14T19:56:00.000Z","date":"2022-02-10","kind":"exercise","acquired":false,"shares":5668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on February 10, 2022, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":11337,"derivative":{"expiration_date":"2024-02-10","underlying":"Common Stock","underlying_shares":5668},"source":{"system":"sec-edgar","filing":"0001209191-22-009563","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122009563/doc4.xml","form_type":"4"}},{"id":2397723,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-14T19:56:00.000Z","date":"2022-02-11","kind":"sale","acquired":false,"shares":2391,"price":12.7411,"value":30463.9701,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.64 to $12.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":7891,"source":{"system":"sec-edgar","filing":"0001209191-22-009563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122009563/doc4.xml","form_type":"4"}},{"id":2397722,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-14T19:56:00.000Z","date":"2022-02-10","kind":"exercise","acquired":true,"shares":5668,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":10282,"source":{"system":"sec-edgar","filing":"0001209191-22-009563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122009563/doc4.xml","form_type":"4"}},{"id":2545425,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-10-08T18:46:22.000Z","date":"2021-10-06","kind":"exercise","acquired":false,"shares":7103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on October 6, 2021, until fully vested subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":14208,"derivative":{"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":7103},"source":{"system":"sec-edgar","filing":"0001209191-21-060111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121060111/doc4.xml","form_type":"4"}},{"id":2545424,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-08T18:46:22.000Z","date":"2021-10-06","kind":"tax_withholding","acquired":false,"shares":2489,"price":12.3686,"value":30785.4454,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":4614,"source":{"system":"sec-edgar","filing":"0001209191-21-060111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121060111/doc4.xml","form_type":"4"}},{"id":2545423,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-08T18:46:22.000Z","date":"2021-10-06","kind":"exercise","acquired":true,"shares":7103,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":7103,"source":{"system":"sec-edgar","filing":"0001209191-21-060111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121060111/doc4.xml","form_type":"4"}},{"id":2663486,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T18:40:05.000Z","date":"2021-06-16","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the total shares on April 20, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":222662,"derivative":{"exercise_price":0.42,"expiration_date":"2030-04-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-041646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121041646/doc4.xml","form_type":"4"}},{"id":2663485,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-17T18:40:05.000Z","date":"2021-06-16","kind":"sale","acquired":false,"shares":20000,"price":16.3484,"value":326968.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.17 to $16.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-041646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121041646/doc4.xml","form_type":"4"}},{"id":2663484,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-17T18:40:05.000Z","date":"2021-06-16","kind":"exercise","acquired":true,"shares":20000,"price":0.42,"value":8400.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-21-041646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121041646/doc4.xml","form_type":"4"}},{"id":2863106,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock (RSU)(Common Stock)","published_at":"2021-02-12T18:11:06.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":17005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on February 10, 2022, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":17005,"derivative":{"expiration_date":"2024-02-10","underlying":"Common Stock","underlying_shares":17005},"source":{"system":"sec-edgar","filing":"0001209191-21-010386","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121010386/doc4.xml","form_type":"4"}},{"id":2863105,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-12T18:11:06.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on February 10, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":15.14,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-010386","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121010386/doc4.xml","form_type":"4"}},{"id":3010812,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units (RSU) (Common Stock)","published_at":"2020-10-07T21:15:12.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":21311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on October 6, 2021, until fully vested subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":21311,"derivative":{"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":21311},"source":{"system":"sec-edgar","filing":"0001209191-20-054253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120054253/doc4.xml","form_type":"4"}},{"id":3010811,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-07T21:15:12.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":62660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests as to 25% of the total shares on October 6, 2021, and thereafter vests as to 1/36 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":62660,"derivative":{"exercise_price":14.77,"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":62660},"source":{"system":"sec-edgar","filing":"0001209191-20-054253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120054253/doc4.xml","form_type":"4"}},{"id":3010810,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-07T21:15:12.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":242662,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in connection with the merger of Private Chinook into the Issuer in exchange for a stock option to acquire 830,500 shares of Private Chinook common stock for $0.12 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on April 20, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully\nvested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":242662,"derivative":{"exercise_price":0.42,"expiration_date":"2030-04-21","underlying":"Common Stock","underlying_shares":242662},"source":{"system":"sec-edgar","filing":"0001209191-20-054253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120054253/doc4.xml","form_type":"4"}}]}